Vildagliptin 50 mg

VILDIABATE 50 is a leading oral antidiabetic medication engineered for the effective management of type 2 diabetes mellitus. Formulated and distributed by Steris Healthcare, a trusted name in high-quality pharmaceuticals, this single-active medication contains vildagliptin 50 mg.

Designed to deliver optimal glycemic control with a low risk of hypoglycemia, VILDIABATE 50 helps patients achieve consistent blood glucose regulation when diet, exercise, or other monotherapies prove insufficient.

What is VILDIABATE 50 for?

VILDIABATE 50 is prescribed primarily for adult patients diagnosed with Type 2 Diabetes Mellitus. It is indicated both as a monotherapy (when metformin is inappropriate due to contraindications or intolerance) and as a combination therapy alongside other anti-diabetic agents like metformin, sulfonylureas, or thiazolidinediones.

Composition Breakdown

• Active Ingredient: Vildagliptin (50 mg)

• Pharmacological Class: Dipeptidyl Peptidase-4 (DPP-4) Inhibitor / Incretin Enhancer

• Primary Objective: To lower fasting plasma glucose (FPG) and postprandial blood glucose (PPG) levels, reducing overall HbA1c in patients with type 2 diabetes.

By enhancing the body’s natural incretin system, VILDIABATE 50 helps restore physiologic insulin secretion in response to meals while suppressing excessive glucagon release.

Why it's important

Uncontrolled type 2 diabetes is a progressive metabolic disorder that causes chronic hyperglycemia (high blood sugar). Over time, elevated circulating glucose damages small and large blood vessels throughout the body, leading to life-threatening vascular complications:

• Microvascular Complications:

  • Diabetic Nephropathy: Structural damage to kidney filters, potentially progressing to end-stage renal disease (ESRD).

  • Diabetic Retinopathy: Damage to retinal blood vessels, leading to impaired vision or blindness.

  • Diabetic Neuropathy: Nerve damage resulting in numbness, chronic pain, and an increased risk of diabetic foot ulcers.

• Macrovascular Complications:

  • Higher incidence of coronary artery disease, myocardial infarction (heart attack), and stroke.

  • Peripheral artery disease leading to poor circulation in lower extremities.

Using a targeted therapy like VILDIABATE 50 by Steris Healthcare helps smooth out glycemic peaks and valleys, protecting vital organs from long-term glucose toxicity.

Key Benefits 

VILDIABATE 50 offers distinct clinical advantages over traditional oral hypoglycemic agents, making it a preferred choice for modern diabetes management.

What are the benefits of vildagliptin 50 mg?

1. Glucose-Dependent Action: Unlike older diabetes medications that force continuous insulin release, vildagliptin 50 mg stimulates insulin secretion only when blood glucose levels are elevated.

2. Minimal Hypoglycemia Risk: Because of its glucose-dependent mechanism, the risk of abnormally low blood sugar drops (hypoglycemia) is exceptionally low when used as monotherapy.

3. Weight-Neutral Profile: VILDIABATE 50 does not cause weight gain, making it an ideal option for overweight or obese patients struggling with metabolic control.

4. Improvement in Pancreatic Islet Function: Clinical evidence shows that regular use enhances both alpha- and beta-cell sensitivity to glucose.

5. Flexible Combination Therapy: Pairs effectively with Metformin, Pioglitazone, or insulin without causing severe drug-drug interactions.

6. Sustained HbA1c Reduction: Delivers reliable long-term reductions in HbA1c levels, helping patients reach their target glycemic goals.

Mechanism of Action 

Understanding the vildagliptin 50 mg uses requires a closer look at how DPP-4 inhibitors interact with the body's incretin system: 

1. Incretin Preservation: When you eat, your intestines naturally secrete incretin hormones (GLP-1 and GIP). These hormones instruct the pancreas to release insulin and signal the liver to stop producing extra glucose.

2. DPP-4 Inhibition: Normally, the enzyme dipeptidyl peptidase-4 (DPP-4) degrades GLP-1 within minutes. Vildagliptin 50 mg binds directly to DPP-4, inhibiting its activity.

3. Balanced Glucose Control: Preserved GLP-1 levels boost insulin release from pancreatic beta cells while suppressing glucagon secretion from alpha cells, effectively lowering both fasting and post-meal glucose levels.

Indications, Efficacy and Clinical Evidence

Clinical Indications

• Type 2 Diabetes Mellitus (Monotherapy): For patients inadequately controlled by diet and exercise alone and for whom metformin is unsuitable.

• Dual Oral Combination: Combined with metformin, a sulfonylurea, or a thiazolidinedione when single-agent therapy fails to achieve glycemic targets.

• Triple Oral Combination: Added to existing dual-therapy regimens (e.g., metformin + sulfonylurea) for advanced glycemic management.

Efficacy & Clinical Evidence

• HbA1c Reduction: Clinical trials demonstrate that vildagliptin 50 mg twice daily (or once daily depending on combination therapy) significantly reduces HbA1c levels by 0.7% to 1.1% over a 24-week period.

• Beta-Cell Support: Long-term clinical studies indicate improved proinsulin-to-insulin ratios, suggesting improved secretory capacity of pancreatic beta cells.

• Renal Safety Profile: Clinical data supports the safe use of vildagliptin across varying degrees of renal function, provided appropriate dose adjustments are made for severe impairment.

Dosage Guidelines 

Precautions & Warnings

Before starting VILDIABATE 50 by Steris Healthcare, discuss your complete medical history with your physician:

• Hepatic Monitoring: Liver function tests (LFTs) should be performed before initiating treatment and monitored at regular clinical intervals. Vildagliptin 50 mg is not recommended in patients with baseline ALT or AST levels greater than 3 times the upper limit of normal.

• Heart Failure: Caution is advised in patients with New York Heart Association (NYHA) functional class I–II heart failure. It is generally not recommended in NYHA class IV.

• Pancreatitis Risk: Discontinue treatment immediately if severe, persistent abdominal pain radiating to the back occurs, as this may indicate acute pancreatitis.

• Skin Disorders: Monitor for cutaneous bullous or exfoliative skin lesions, which have been reported rarely with DPP-4 inhibitors.

• Pregnancy & Lactation: VILDIABATE 50 is not recommended during pregnancy or while breastfeeding due to a lack of sufficient human clinical trial safety data.

Side Effects 

Most patients tolerate tab vildagliptin 50 mg well. However, like all pharmaceutical agents, it may produce mild to moderate side effects in some individuals:

• Mild headache or dizziness

• Mild gastrointestinal disturbances (nausea, flatulence, constipation)

• Nasopharyngitis (upper respiratory tract symptoms, sore throat)

• Peripheral edema (mild swelling of hands or ankles, usually when combined with TZD)

• Joint pain (arthralgia)

Frequently Asked Questions

Q1. What is vildagliptin 50 mg used for?

Vildagliptin 50 mg is an oral antidiabetic medication used to lower blood sugar levels in adults with type 2 diabetes mellitus by increasing insulin production and decreasing glucagon levels.

Q2. What is vildagliptin 50 mg?

VILDIABATE 50 is a brand name for vildagliptin 50 mg tablets, manufactured and marketed by Steris Healthcare for the treatment of type 2 diabetes.

Q3. What are the uses of vildagliptin 50 mg in Hindi?

vildagliptin 50 mg uses in hindi: टेनेलिग्लिप्टिन और विल्डाग्लिप्टिन जैसी दवाएं टाइप 2 डायबिटीज में इस्तेमाल होती हैं। विल्डाग्लिप्टिन 50 एमजी का मुख्य उपयोग ब्लड शुगर को नियंत्रित करने और इंसुलिन स्राव को बढ़ाने के लिए किया जाता है।

Q4. What is the typical vildagliptin 50 mg price?

The vildagliptin 50 mg price varies depending on the brand, packaging size, and retail pharmacy discounts. Generic and branded options like VILDIABATE 50 offer cost-effective treatment. Check your local pharmacy or official distributor for exact pricing.

Q5. Can tab vildagliptin 50 mg cause weight gain?

No, tab vildagliptin 50 mg is weight-neutral. Unlike sulfonylureas or insulin, it does not typically cause weight gain during treatment.

Q6. Should I take vildagliptin 50 mg before or after food?

VILDIABATE 50 can be taken with or without food. However, taking it at the same time every day helps maintain consistent blood glucose control.

Q7. Does vildagliptin 50 mg cause low blood sugar (hypoglycemia)?

When used alone (monotherapy), vildagliptin 50 mg has a very low risk of hypoglycemia because its action is glucose-dependent. The risk increases if combined with sulfonylureas or insulin.

Q8. Can I take vildagliptin 50 mg if I have kidney problems?

VILDIABATE 50 can be used in patients with renal impairment, but dose adjustments may be necessary depending on the degree of kidney function. Consult your physician first.

Q9. Is liver testing necessary while taking vildagliptin 50 mg?

Yes, liver function tests (LFTs) should be performed before starting vildagliptin 50 mg and checked periodically during treatment to monitor liver enzyme levels.

Q10. How does vildagliptin 50 mg differ from metformin?

Metformin primarily reduces glucose production in the liver and improves insulin sensitivity, whereas VILDIABATE 50 (vildagliptin) preserves incretin hormones to stimulate mealtime insulin secretion and suppress glucagon. They are often prescribed together for complementary effects.

Q11. Can vildagliptin 50 mg be used in type 1 diabetes?

No, VILDIABATE 50 is only indicated for Type 2 Diabetes Mellitus. It is ineffective in type 1 diabetes, where the body cannot produce insulin.

Q12. What should I do if I miss a dose of Tab Vildagliptin 50 mg?

Take the missed tablet as soon as you remember. If it is almost time for your next scheduled dose, skip the missed tablet and resume your regular schedule. Do not double the dose.

Conclusion

VILDIABATE 50 (vildagliptin 50 mg) by Steris Healthcare offers a reliable, weight-neutral, and low-hypoglycemia solution for individuals managing type 2 diabetes mellitus. Through its targeted DPP-4 inhibition, it restores healthy physiological insulin responses and keeps blood sugar levels balanced throughout the day. When paired with proper nutrition, exercise, and regular clinical monitoring, VILDIABATE 50 serves as a cornerstone of effective diabetes management.

For Further Information:  

Mail Us: contact@sterispharma.com or info@sterispharma.com

Call Now: +91 8824175417, +91 9982524671

Buy Now